title: Proteasome inhibitor MG-132 induces MCPIP1 expression.
abstract: The proteasome is a protein complex responsible for the degradation of polyubiquitin-tagged proteins. Besides the removal of target proteins, the proteasome also participates in the regulation of gene transcription in both proteolytic and non-proteolytic fashion. In this study the effect of proteasome inhibition on the basal expression of monocyte chemotactic protein-1 induced protein 1 (MCPIP1) was examined. Treatment of HepG2 or HeLa cells with proteasome inhibitor MG-132 resulted in a significant increase of MCPIP1 expression, both at mRNA and protein level. Interestingly, MG-132 did not alter MCPIP1 stability. Instead, the observed protein increase was blocked by actinomycin D, suggesting the involvement of de novo mRNA synthesis in the increase of MCPIP1 protein following MG-132 treatment. Using several inhibitors we determined the participation of extracellular-signal-regulated kinase 1/2 and p38 kinases in MCPIP1 upregulation by MG-132. Our findings show for the first time the impact of proteasome inhibition on MCPIP1 protein expression by modulation of the activity of intracellular signaling pathways. Overexpression of MCPIP1-myc protein decreased the viability of HeLa cells but not HepG2 cells, which correlates with the increased susceptibility of HeLa cells to MG-132 toxicity. Notably, both MG-132 treatment and MCPIP1-myc overexpression led to the activation of apoptosis, as revealed by the induction of caspases 3/7 in both types of cell lines. This suggests the involvement of MCPIP1 upregulation in toxic properties of proteasome inhibition, which is an acknowledged approach to the treatment of several cancer types.
authors.affiliation: Department of General Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.
authors.forename: Lukasz
authors.initials: L
authors.lastname: Skalniak
authors.forename: Aleksander
authors.initials: A
authors.lastname: Koj
authors.forename: Jolanta
authors.initials: J
authors.lastname: Jura
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects / Q000235:genetics; D006367:HeLa Cells; D056945:Hep G2 Cells; D006801:Humans; D007976:Leupeptins / Q000494:pharmacology*; D061988:Proteasome Inhibitors / Q000494:pharmacology*; D012260:Ribonucleases; D014157:Transcription Factors / Q000096:biosynthesis / Q000235:genetics*; D015854:Up-Regulation / Q000187:drug effects / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D007976:Leupeptins; D061988:Proteasome Inhibitors; D014157:Transcription Factors; D012260:Ribonucleases; C510646:ZC3H12A protein, human; C072553:benzyloxycarbonylleucyl-leucyl-leucine aldehyde
references.citation: Clin Cancer Res. 1999 Sep;5(9):2638-45
references.pmid: 10499643
references.citation: J Mol Cell Cardiol. 2011 Aug;51(2):177-86
references.pmid: 21616078
references.citation: J Biol Chem. 2011 Dec 2;286(48):41692-41700
references.pmid: 21971051
references.citation: J Biol Chem. 2010 May 21;285(21):16096-104
references.pmid: 20335171
references.citation: Nature. 2009 Apr 30;458(7242):1185-90
references.pmid: 19322177
references.citation: PLoS One. 2008 Aug 06;3(8):e2880
references.pmid: 18682727
references.citation: Nat Cell Biol. 2002 May;4(5):E113-6
references.pmid: 11988749
references.citation: Nat Immunol. 2011 Oct 30;12(12):1167-75
references.pmid: 22037600
references.citation: J Biol Chem. 1998 Jan 16;273(3):1409-19
references.pmid: 9430676
references.citation: Expert Opin Investig Drugs. 2008 Jun;17(6):879-95
references.pmid: 18491989
references.citation: FEBS J. 2009 Dec;276(24):7386-99
references.pmid: 19909337
references.citation: Blood. 2012 Aug 2;120(5):947-59
references.pmid: 22645181
references.citation: Oncogene. 1999 May 27;18(21):3213-25
references.pmid: 10359527
references.citation: Mol Cell Biol. 2006 Mar;26(6):2408-18
references.pmid: 16508015
references.citation: Biochem Biophys Res Commun. 2013 Jan 25;430(4):1277-82
references.pmid: 23261467
references.citation: Curr Hematol Malig Rep. 2012 Dec;7(4):258-66
references.pmid: 23065395
references.citation: Nat Biotechnol. 2010 Dec;28(12):1248-50
references.pmid: 21139605
references.citation: Curr Top Med Chem. 2011 Dec;11(23):2888-905
references.pmid: 21824109
references.citation: Mol Cell Biochem. 2006 Jul;287(1-2):13-9
references.pmid: 16733806
references.citation: PLoS One. 2012;7(11):e49841
references.pmid: 23185455
references.citation: Cardiovasc Res. 2010 Sep 1;87(4):665-74
references.pmid: 20356868
references.citation: BMC Mol Biol. 2010 Feb 06;11:14
references.pmid: 20137095
references.citation: Circ Res. 2006 May 12;98(9):1177-85
references.pmid: 16574901
references.citation: Brain Res Bull. 2009 Apr 29;79(2):97-103
references.pmid: 19185603
references.citation: J Biol Chem. 1999 Jul 9;274(28):19965-72
references.pmid: 10391945
references.citation: Mol Cell Biol. 2003 Jan;23(2):425-36
references.pmid: 12509443
references.citation: J Biol Chem. 2008 Mar 7;283(10):6337-46
references.pmid: 18178554
references.citation: Am J Respir Cell Mol Biol. 2002 Aug;27(2):234-43
references.pmid: 12151316
references.citation: Am J Respir Cell Mol Biol. 1998 Aug;19(2):259-68
references.pmid: 9698598
references.citation: Immunol Cell Biol. 2002 Jun;80(3):226-30
references.pmid: 12067409
references.citation: Mol Biol Cell. 2005 Dec;16(12):5579-91
references.pmid: 16195339
references.citation: Cancer Biol Ther. 2006 Jul;5(7):745-8
references.pmid: 16861900
references.citation: J Biochem. 1996 Mar;119(3):572-6
references.pmid: 8830056
references.citation: Blood. 2007 Nov 1;110(9):3281-90
references.pmid: 17591945
references.citation: FEBS J. 2009 Oct;276(20):5892-905
references.pmid: 19747262
references.citation: Biochem J. 2010 Jan 27;426(1):43-53
references.pmid: 19925454
references.citation: J Biol Chem. 2009 Oct 2;284(40):27620-8
references.pmid: 19666473
references.citation: Nat Methods. 2012 Jul;9(7):671-5
references.pmid: 22930834
references.citation: Cancer Lett. 2010 Jul 1;293(1):15-22
references.pmid: 20133049
references.citation: J Mol Cell Biol. 2011 Dec;3(6):360-8
references.pmid: 21990425
references.citation: Biochim Biophys Acta. 2012 Oct;1823(10):1905-13
references.pmid: 22771441
references.citation: Semin Cell Dev Biol. 2012 Jul;23(5):523-9
references.pmid: 22430757
references.citation: Biochem J. 2004 May 1;379(Pt 3):587-93
references.pmid: 14731112
references.citation: Mol Cell. 2011 Nov 4;44(3):424-36
references.pmid: 22055188